Safety and Tolerability of Intranasal Insulin in Parkinson’s Disease (P11-5.018)
To determine the safety and tolerability of three doses of intranasal (IN) insulin in patients with Parkinson’s disease (PD)
Authors
- S.K. Gustafson
- Leah R. Hanson (ORCID: https://orcid.org/0000-0002-2847-7949)
- Aleta L. Svitak
- William H. Frey (ORCID: https://orcid.org/0000-0002-6373-0794)
- Kathryn A Wyman‐Chick (ORCID: https://orcid.org/0000-0002-5057-5094)
- Bhavani Kashyap (ORCID: https://orcid.org/0000-0003-4823-9638)
- Meghan O’Brien
- Julia C. Johnson
Institutions
- HealthPartners (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000212405
- Primary Topic
- Pharmaceutical studies and practices
- Type
- article
- Field-Weighted Citation Impact
- 0.00